THE GREATEST GUIDE TO AGO TUMOR

Molecular typing relies on molecular genetic screening and is not nevertheless routinely offered. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple adverse) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 can be valuable, but a pot